Turmeric and curcumin: safety
Liver warnings and interactions of turmeric supplements with medicines.
Key points
- Australia’s TGA warns of rare, sometimes severe liver injury from turmeric or curcumin supplements; people with current or past liver disease are advised to avoid them. If jaundice, dark urine or unusual weakness occurs, stop taking the supplement and seek medical help. [1] See the evidence 1
- A substantial INR increase after a turmeric supplement has been reported with warfarin; frequency cannot be determined from one case. Before taking a supplement, discuss it with the doctor managing warfarin. [2] See the evidence 1
- Curcumin with piperine altered exposure to an active tamoxifen metabolite in a small study. Discuss turmeric or curcumin supplements with your oncologist before taking them. [3] [4] See the evidence 1
Practical guide
Check the conclusions and whether they apply to your situation.
Concentrated supplements and dietary spice amounts are considered separately.
Key points
Why these conclusions
Risks and interactions
The DILIN series described 10 cases of liver injury after turmeric supplements. A case series does not determine risk frequency or the independent contribution of piperine. [5]
In a small crossover study of patients on tamoxifen, endoxifen exposure with curcumin changed by −7.7% (95% CI −15.4 to +0.7) versus tamoxifen without a supplement; the interval includes no difference. [3]
In a small crossover study of patients on tamoxifen, curcumin with piperine changed endoxifen exposure by −12.4% (95% CI −21.9 to −1.9) versus tamoxifen without a supplement; this is a pharmacokinetic measure, not a cancer treatment outcome. [3]
A regulator reports one case of INR >10 after a turmeric supplement during warfarin treatment. This is a signal for interaction assessment, with no known frequency or universal preoperative regimen. [2]
A short RCT of a fenugreek, ginger and turmeric blend does not establish the safety of turmeric alone during lactation or infant growth. The exact blend dose was not confirmed. [6]
Averaging short-term liver enzyme measures in turmeric or curcumin supplement studies does not exclude rare serious liver injury. [1]
Turmeric or curcumin supplements may cause nausea, reflux, diarrhea and constipation; short RCTs and the absence of individual events do not exclude rare harm. [7]
TGA describes rare, sometimes severe liver injury from turmeric or curcumin supplements; it is especially important not to transfer safety of dietary amounts to concentrates. Spontaneous cases do not provide frequency per user; stop and seek medical care for jaundice or dark urine. [1]
Safety of high-dose turmeric or curcumin supplements during pregnancy, lactation and in children is incompletely established; TGA recommends avoiding such supplements with a history of liver disease, with dietary amounts considered separately. [8] [1]
The DILIN series described 10 cases of liver injury associated with turmeric supplements; a case series does not provide risk frequency. [5]
Turmeric and curcumin supplements may cause nausea, reflux, diarrhea or constipation. [7]
TGA warns of rare, sometimes severe liver injury from turmeric or curcumin supplements. Risk may be higher with enhanced-absorption supplements or high doses. Stop and seek medical help for jaundice, dark urine or unusual weakness; avoid such supplements with current or past liver disease. [1]
A trial of a fenugreek, ginger and turmeric blend does not establish the safety of a turmeric supplement alone during lactation. [6]
Turmeric supplements may be unsafe during pregnancy; safety of amounts above dietary levels during breastfeeding is poorly studied. [7]
Tamoxifen: In a small study, curcumin with piperine reduced endoxifen exposure; the reduction with curcumin without piperine was less certain. Discuss turmeric or curcumin supplements with your oncologist before taking them. [3] [4]
Warfarin: A substantial rise in INR and bleeding risk have been reported with a turmeric supplement; frequency cannot be determined from one case. Before taking a supplement, discuss it with the doctor managing warfarin and agree INR monitoring. [2]
The DILIN series described 10 cases of liver injury after turmeric supplements. A case series does not determine risk frequency or the independent contribution of piperine.
The DILIN series described 10 cases of liver injury after turmeric supplements. A case series does not determine risk frequency or the independent contribution of piperine. [5]
In a small crossover study of patients on tamoxifen, endoxifen exposure with curcumin changed by −7.7% (95% CI −15.4 to +0.7) versus tamoxifen without a supplement; the interval includes no difference.
| Parameter | Data |
|---|---|
| Result | In a small crossover study of patients on tamoxifen, endoxifen exposure with curcumin changed by −7.7% (95% CI −15.4 to +0.7) versus tamoxifen without a supplement; the interval includes no difference. Endoxifen AUC₀–₂₄ −7.7% (95% CI −15.4 to +0.7). |
| Participants | Patients with breast cancer taking tamoxifen 20–30 mg/day |
| Form | Curcumin 1200 mg orally three times daily in addition to tamoxifen |
| Dose | Curcumin 1200 mg orally three times daily in addition to tamoxifen |
| Dose basis | Curcumin 1200 mg orally three times daily in addition to tamoxifen |
| Comparator | Tamoxifen without supplement, crossover comparison |
| Duration | Short dosing periods, AUC over 24 hours |
| Confidence | 1/4: Small crossover study. No grounds for a separate downgrade. Pharmacokinetics without measurement of cancer outcomes. Small sample; interval without piperine includes zero. No specific data for a separate downgrade. |
| Evidence base | 1 crossover study; separate condition |
| Sources | [3] |
In a small crossover study of patients on tamoxifen, curcumin with piperine changed endoxifen exposure by −12.4% (95% CI −21.9 to −1.9) versus tamoxifen without a supplement; this is a pharmacokinetic measure, not a cancer treatment outcome.
| Parameter | Data |
|---|---|
| Result | In a small crossover study of patients on tamoxifen, curcumin with piperine changed endoxifen exposure by −12.4% (95% CI −21.9 to −1.9) versus tamoxifen without a supplement; this is a pharmacokinetic measure, not a cancer treatment outcome. Endoxifen AUC₀–₂₄ −12.4% (95% CI −21.9 to −1.9). |
| Participants | Patients with breast cancer taking tamoxifen 20–30 mg/day |
| Form | Curcumin 1200 mg + piperine 10 mg orally three times daily in addition to tamoxifen |
| Dose | Curcumin 1200 mg + piperine 10 mg orally three times daily in addition to tamoxifen |
| Dose basis | Curcumin 1200 mg + piperine 10 mg orally three times daily in addition to tamoxifen |
| Comparator | Tamoxifen without supplement, crossover comparison |
| Duration | Short dosing periods, AUC over 24 hours |
| Confidence | 1/4: Small crossover study. No grounds for a separate downgrade. Pharmacokinetics without measurement of cancer outcomes. Small sample; interval without piperine includes zero. No specific data for a separate downgrade. |
| Evidence base | 1 crossover study; separate condition |
| Sources | [3] |
A regulator reports one case of INR >10 after a turmeric supplement during warfarin treatment. This is a signal for interaction assessment, with no known frequency or universal preoperative regimen.
A regulator reports one case of INR >10 after a turmeric supplement during warfarin treatment. This is a signal for interaction assessment, with no known frequency or universal preoperative regimen. [2]
A short RCT of a fenugreek, ginger and turmeric blend does not establish the safety of turmeric alone during lactation or infant growth. The exact blend dose was not confirmed.
A short RCT of a fenugreek, ginger and turmeric blend does not establish the safety of turmeric alone during lactation or infant growth. The exact blend dose was not confirmed. [6]
Averaging short-term liver enzyme measures in turmeric or curcumin supplement studies does not exclude rare serious liver injury.
Averaging short-term liver enzyme measures in turmeric or curcumin supplement studies does not exclude rare serious liver injury. [1]
Turmeric or curcumin supplements may cause nausea, reflux, diarrhea and constipation; short RCTs and the absence of individual events do not exclude rare harm.
Turmeric or curcumin supplements may cause nausea, reflux, diarrhea and constipation; short RCTs and the absence of individual events do not exclude rare harm. [7]
TGA describes rare, sometimes severe liver injury from turmeric or curcumin supplements; it is especially important not to transfer safety of dietary amounts to concentrates. Spontaneous cases do not provide frequency per user; stop and seek medical care for jaundice or dark urine.
TGA describes rare, sometimes severe liver injury from turmeric or curcumin supplements; it is especially important not to transfer safety of dietary amounts to concentrates. Spontaneous cases do not provide frequency per user; stop and seek medical care for jaundice or dark urine. [1]
Safety of high-dose turmeric or curcumin supplements during pregnancy, lactation and in children is incompletely established; TGA recommends avoiding such supplements with a history of liver disease, with dietary amounts considered separately.
Safety of high-dose turmeric or curcumin supplements during pregnancy, lactation and in children is incompletely established; TGA recommends avoiding such supplements with a history of liver disease, with dietary amounts considered separately. [8] [1]
The DILIN series described 10 cases of liver injury associated with turmeric supplements; a case series does not provide risk frequency.
The DILIN series described 10 cases of liver injury associated with turmeric supplements; a case series does not provide risk frequency. [5]
Turmeric and curcumin supplements may cause nausea, reflux, diarrhea or constipation.
Turmeric and curcumin supplements may cause nausea, reflux, diarrhea or constipation. [7]
TGA warns of rare, sometimes severe liver injury from turmeric or curcumin supplements. Risk may be higher with enhanced-absorption supplements or high doses. Stop and seek medical help for jaundice, dark urine or unusual weakness; avoid such supplements with current or past liver disease.
TGA warns of rare, sometimes severe liver injury from turmeric or curcumin supplements. Risk may be higher with enhanced-absorption supplements or high doses. Stop and seek medical help for jaundice, dark urine or unusual weakness; avoid such supplements with current or past liver disease. [1]
A trial of a fenugreek, ginger and turmeric blend does not establish the safety of a turmeric supplement alone during lactation.
A trial of a fenugreek, ginger and turmeric blend does not establish the safety of a turmeric supplement alone during lactation. [6]
Turmeric supplements may be unsafe during pregnancy; safety of amounts above dietary levels during breastfeeding is poorly studied.
Turmeric supplements may be unsafe during pregnancy; safety of amounts above dietary levels during breastfeeding is poorly studied. [7]
Tamoxifen: In a small study, curcumin with piperine reduced endoxifen exposure; the reduction with curcumin without piperine was less certain. Discuss turmeric or curcumin supplements with your oncologist before taking them.
Tamoxifen: In a small study, curcumin with piperine reduced endoxifen exposure; the reduction with curcumin without piperine was less certain. Discuss turmeric or curcumin supplements with your oncologist before taking them. [3] [4]
Warfarin: A substantial rise in INR and bleeding risk have been reported with a turmeric supplement; frequency cannot be determined from one case. Before taking a supplement, discuss it with the doctor managing warfarin and agree INR monitoring.
Warfarin: A substantial rise in INR and bleeding risk have been reported with a turmeric supplement; frequency cannot be determined from one case. Before taking a supplement, discuss it with the doctor managing warfarin and agree INR monitoring. [2]
Sources
- TGA Medicines containing turmeric or curcumin - risk of liver injury. https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/medicines-containing-turmeric-or-curcumin-risk-liver-injury
- Medsafe: Beware turmeric/curcumin containing products can interact with warfarin. https://medsafe.govt.nz/safety/EWS/2018/Turmeric.asp
- Impact of Curcumin (with or without Piperine) on the Pharmacokinetics of Tamoxifen. https://pmc.ncbi.nlm.nih.gov/articles/PMC6468355/
- Impact of Curcumin (with or without Piperine) on the Pharmacokinetics of Tamoxifen. https://pubmed.ncbi.nlm.nih.gov/30909366/
- Liver Injury Associated with Turmeric: Ten Cases from DILIN. https://pmc.ncbi.nlm.nih.gov/articles/PMC9892270/
- Effects of Fenugreek, Ginger, and Turmeric Supplementation on Human Milk Volume and Nutrient Content in Breastfeeding Mothers: A Randomized Double-Blind Controlled Trial. https://pubmed.ncbi.nlm.nih.gov/30411974/
- NCCIH Turmeric: Usefulness and Safety. https://www.nccih.nih.gov/health/turmeric
- Turmeric. https://www.ncbi.nlm.nih.gov/books/NBK501846/
Methodology: Subpages evidence-led supplement pipeline v1